Neuros Medical, a medical device company focused on alleviating chronic post-amputation pain, received $25 million from Trinity Capital, CEO David Veino tells Axios exclusively.
Why it matters: Post-amputation pain — including phantom limb and residual limb (or "stump") pain — impacts nearly 1 million Americans, and Neuros Medical offers an alternative to highly addictive opioids.
